SLANSKY RICHARD B 4
4 · ONCOSEC MEDICAL Inc · Filed Jan 17, 2018
Insider Transaction Report
Form 4
SLANSKY RICHARD B
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-12+100,000→ 347,500 totalExercise: $1.32From: 2018-01-12Exp: 2027-11-04→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]OncoSec's (ONCS) stock closing price was $1.32 on November 4, 2017.
- [F2]The Stock Options to purchase 100,000 shares of common stock of the issuer were approved by OncoSec's Board of Directors on November 4, 2017 ("Grant Date") and the contingency restriction was removed after OncoSec's Annual Stockholders Meeting held on January 12, 2018.
- [F3]25% vested on January 12, 2018, and the remaining 75% are vesting in 36 equal monthly increments, which began on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.